APP and Alzheimer disease: In addition, neither APOE4 nor disease status affected APP derivatives including sAPPα, sAPPβ, and CTF-β at week 12 (Fig. 3d–f), whereas APOE4 but not AD status was associated with lower levels of full-length APP (Fig. 3g, h).